Part of the renowned Braunwald family of references, Hypertension: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on every aspect of managing and treating patients who suffer from hypertensive disorders. An invaluable resource for cardiologists, endocrinologists, and nephrologists, this one-stop reference covers all the latest developments from basic science to clinical trials and guidelines related to the treatment of common to complex hypertension. Now fully updated from cover to cover, the 4th Edition offers unparalleled coverage of hypertension in an accessible and user-friendly manner.
Thoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities.
Includes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine/Digital Health.
Contains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.
Provides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format.
Covers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans.
Highlights combination drug therapies and management of chronic complications of hypertension.
Offers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. iv 5. Contributors - p. v 6. Foreword - p. xii 7. Preface - p. xiii 8. Acknowledgments - p. xiv 9. Braunwald’s Heart Disease Family of Books - p. xvii 10. Updates to the Book - p. xviii 11. Section I: Epidemiology and Preventive Strategies - p. xviii 12. 1: General Population and Global Cardiovascular Risk Prediction - p. 1 13. 2: Diet and Hypertension - p. 17 14. 3: Exercise and Hypertension - p. 49 15. 4: Hypertension in Women - p. 58 16. Section II: Pathophysiology - p. 69 17. 5: Pathophysiology of Hypertension - p. 71 18. 6: Genetics of Hypertension - p. 87 19. 7: Inflammation and Immunity in Hypertension - p. 93 20. Section III: Diagnosis and Evaluation - p. 100 21. 8: The Environment and High Blood Pressure - p. 101 22. 9: Office Blood Pressure Measurement - p. 106 23. 10: Home Monitoring of Blood Pressure - p. 123 24. 11: Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management - p. 133 25. 12: White Coat and Masked Hypertension - p. 144 26. 13: Renovascular Hypertension and Ischemic Nephropathy - p. 161 27. 14: Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States - p. 174 28. 15: Secondary Hypertension: Pheochromocytoma and Paraganglioma - p. 187 29. 16: Sleep Disruption and Blood Pressure - p. 198 30. Section IV: Risk Stratification - p. 207 31. 17: The Natural History of Untreated Hypertension - p. 209 32. 18: Isolated Systolic Hypertension - p. 220 33. 19: Assessment of Hypertension-Mediated Organ Damage - p. 229 34. Section V: Antihypertensive Therapy - p. 242 35. 20: Diuretics Therapy - p. 243 36. 21: Calcium Channel Blockers - p. 252 37. 22: Renin Angiotensin Aldosterone System Blockers - p. 258 38. 23: Aldosterone and Hypertension - p. 274 39. 24: β-Blockers, Central Sympathetic Agents, and Direct Vasodilators - p. 285 40. 25: Peripheral Alpha Blockers - p. 297 41. 26: Initial Combination Therapies - p. 304 42. 27: Device Therapies for Hypertension - p. 310 43. 28: The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle - p. 316 44. Section VI: Hypertension Management Approaches - p. 322 45. 29: Approach to Difficult to Manage Primary Hypertension - p. 323 46. 30: Team-Based Care for Hypertension Management - p. 332 47. 31: Medication Adherence: Focus on Improvement - p. 339 48. 32: Digital Health and Telemedicine for Hypertension - p. 350 49. Section VII: Hypertension Management With Comorbidities - p. 362 50. 33: Ischemic Heart Disease - p. 363 51. 34: Heart Failure - p. 377 52. 35: Hypertension and Chronic Kidney Disease Including Dialysis - p. 393 53. 36: Transplant Hypertension - p. 405 54. 37: Obesity and Hypertension: Pathophysiology and Treatment - p. 413 55. 38: Cerebrovascular Disease - p. 427 56. 39: Diabetes Mellitus: Management of Hypertension in Diabetes - p. 439 57. 40: Onco-Hypertension: Anticancer Therapy-Associated Hypertension - p. 456 58. 41: Autonomic Dysfunction and Orthostatic Hypotension - p. 466 59. 42: Dyslipidemia - p. 476 60. 43: Aorta and Peripheral Arterial Disease in Hypertension - p. 489 61. Section VIII: Special Populations - p. 500 62. 44: Hypertension in Pregnancy - p. 501 63. 45: Hypertension in Older People - p. 518 64. 46: Hypertension in African Americans - p. 528 65. 47: Resistant Hypertension - p. 542 66. 48: Hypertensive Emergencies and Urgencies - p. 556 67. 49: Hypertension in Children: Diagnosis and Treatment - p. 564 68. Appendix: Meta-Analyses of Blood Pressure Lowering Trials - p. 577 69. Index - p. 593
Part of the renowned Braunwald family of references, Hypertension: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on every aspect of managing and treating patients who suffer from hypertensive disorders. An invaluable resource for cardiologists, endocrinologists, and nephrologists, this one-stop reference covers all the latest developments from basic science to clinical trials and guidelines related to the treatment of common to complex hypertension. Now fully updated from cover to cover, the 4th Edition offers unparalleled coverage of hypertension in an accessible and user-friendly manner.
Thoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities.
Includes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine/Digital Health.
Contains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.
Provides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format.
Covers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans.
Highlights combination drug therapies and management of chronic complications of hypertension.
Offers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. iv 5. Contributors - p. v 6. Foreword - p. xii 7. Preface - p. xiii 8. Acknowledgments - p. xiv 9. Braunwald’s Heart Disease Family of Books - p. xvii 10. Updates to the Book - p. xviii 11. Section I: Epidemiology and Preventive Strategies - p. xviii 12. 1: General Population and Global Cardiovascular Risk Prediction - p. 1 13. 2: Diet and Hypertension - p. 17 14. 3: Exercise and Hypertension - p. 49 15. 4: Hypertension in Women - p. 58 16. Section II: Pathophysiology - p. 69 17. 5: Pathophysiology of Hypertension - p. 71 18. 6: Genetics of Hypertension - p. 87 19. 7: Inflammation and Immunity in Hypertension - p. 93 20. Section III: Diagnosis and Evaluation - p. 100 21. 8: The Environment and High Blood Pressure - p. 101 22. 9: Office Blood Pressure Measurement - p. 106 23. 10: Home Monitoring of Blood Pressure - p. 123 24. 11: Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management - p. 133 25. 12: White Coat and Masked Hypertension - p. 144 26. 13: Renovascular Hypertension and Ischemic Nephropathy - p. 161 27. 14: Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States - p. 174 28. 15: Secondary Hypertension: Pheochromocytoma and Paraganglioma - p. 187 29. 16: Sleep Disruption and Blood Pressure - p. 198 30. Section IV: Risk Stratification - p. 207 31. 17: The Natural History of Untreated Hypertension - p. 209 32. 18: Isolated Systolic Hypertension - p. 220 33. 19: Assessment of Hypertension-Mediated Organ Damage - p. 229 34. Section V: Antihypertensive Therapy - p. 242 35. 20: Diuretics Therapy - p. 243 36. 21: Calcium Channel Blockers - p. 252 37. 22: Renin Angiotensin Aldosterone System Blockers - p. 258 38. 23: Aldosterone and Hypertension - p. 274 39. 24: β-Blockers, Central Sympathetic Agents, and Direct Vasodilators - p. 285 40. 25: Peripheral Alpha Blockers - p. 297 41. 26: Initial Combination Therapies - p. 304 42. 27: Device Therapies for Hypertension - p. 310 43. 28: The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle - p. 316 44. Section VI: Hypertension Management Approaches - p. 322 45. 29: Approach to Difficult to Manage Primary Hypertension - p. 323 46. 30: Team-Based Care for Hypertension Management - p. 332 47. 31: Medication Adherence: Focus on Improvement - p. 339 48. 32: Digital Health and Telemedicine for Hypertension - p. 350 49. Section VII: Hypertension Management With Comorbidities - p. 362 50. 33: Ischemic Heart Disease - p. 363 51. 34: Heart Failure - p. 377 52. 35: Hypertension and Chronic Kidney Disease Including Dialysis - p. 393 53. 36: Transplant Hypertension - p. 405 54. 37: Obesity and Hypertension: Pathophysiology and Treatment - p. 413 55. 38: Cerebrovascular Disease - p. 427 56. 39: Diabetes Mellitus: Management of Hypertension in Diabetes - p. 439 57. 40: Onco-Hypertension: Anticancer Therapy-Associated Hypertension - p. 456 58. 41: Autonomic Dysfunction and Orthostatic Hypotension - p. 466 59. 42: Dyslipidemia - p. 476 60. 43: Aorta and Peripheral Arterial Disease in Hypertension - p. 489 61. Section VIII: Special Populations - p. 500 62. 44: Hypertension in Pregnancy - p. 501 63. 45: Hypertension in Older People - p. 518 64. 46: Hypertension in African Americans - p. 528 65. 47: Resistant Hypertension - p. 542 66. 48: Hypertensive Emergencies and Urgencies - p. 556 67. 49: Hypertension in Children: Diagnosis and Treatment - p. 564 68. Appendix: Meta-Analyses of Blood Pressure Lowering Trials - p. 577 69. Index - p. 593
